Adagene Inc. Sponsored ADR (ADAG) vs Canton Strategic Holdings, Inc. (CNTN)

Adagene Inc. Sponsored ADR and Canton Strategic Holdings, Inc. are both Biotechnology companies. Adagene Inc. Sponsored ADR and Canton Strategic Holdings, Inc. are of similar size ($200.1M and $191.2M). Adagene Inc. Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Canton Strategic Holdings, Inc. trades at 13.7×. Across the 9 metrics below, Canton Strategic Holdings, Inc. leads on 5 and Adagene Inc. Sponsored ADR on 4.

Valuation

Metric ADAG CNTN Biotechnology median
P/E n/m 13.67 7.88
P/S n/m n/m 11.47
P/B n/m 1.23 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (17.68%) 7.31% (28.84%)
Free cash flow yield 0.00% (3.96%) (23.03%)

Profitability

Metric ADAG CNTN Biotechnology median
Gross margin — — 65.16%
Operating margin — 0.00% 0.00%
Net margin — 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (43.10%) (57.72%)
Return on assets 0.00% (34.60%) (49.22%)
Return on invested capital 0.00% (8.11%) 0.00%

Growth

Metric ADAG CNTN Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 49.15% 88.10% —
Revenue growth, 5-year CAGR 61.38% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ADAG CNTN Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 5.02 15.70 4.73
Net debt to EBITDA 3.46 0.85 0.96

Dividend

Metric ADAG CNTN Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ADAG CNTN Biotechnology median
Market cap 200.08m 191.23m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack